Coordination Pharmaceuticals Inc

ELK GROVE VILLAGE, IL · Biotech · Private

Nanoscale metal-organic frameworks (nMOFs) conjugated with immune modulators for radiation-activated cancer immunotherapy

Claim this profile

Follows are private to you and power your alerts

Updated · coordinationpharma.com

Sector
Biotech
Headquarters
ELK GROVE VILLAGE, IL
Latest Form D
$18M, Sep 2021
Total capital
$18.6M
Federal grants
$300K
1 award
Rank in peer group#8 of 392
Private capital raised
$18M
1 Form D · last Sep 2021
61 months since last filing
Federal contracts
$300K
1 award · Health and Human S
Rank in Biotech#266 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20212022FEDERAL ↑EQUITY ↓Cumulative $18.3M$300K1st Form D$18M
20212022FEDERAL ↑EQUITY ↓Cumulative $18.3M$300K1st Form D$18M

Latest events

  • Federal contractHealth and Human S · Detection, Diagnosis, Treatment, Prevention And Research Of Pediatric Cancers And/or Rare Cancer.$300K
  • Private capital raisedForm D · SEC · 1st filing$18M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 392 peers

Line = median

Biotech · Molecule

  • Federal grants#8 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ze-Qi XuResearcherExecutive OfficerLinked by $300K in grants as PI
  • Jianhua YangDirectorNamed in SEC Form D filings
  • Wenbin LinDirectorNamed in SEC Form D filings
  • Xiaochang DaiDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Oncotab, Inc.Similar federal contract value in Biotech · $300K in contracts
  • Delphi Genomics, LLCSimilar federal contract value in Biotech · $300K in contracts
  • GENECURE LLCSimilar federal contract value in Biotech · $300K in contracts
  • Regulus Therapeutics Inc.Similar federal contract value in Biotech · $300K in contracts
  • ADT PHARMACEUTICALS, LLCSimilar federal contract value in Biotech · $300K in contracts
  • NECTAGEN INCSimilar federal contract value in Biotech · $300K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .